NAYIRI KETCHEDJIAN: Open Payments
NPI 1316256548 · LOS ANGELES, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$469 in 5 payments from 3 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $469
Food & beverage: $469
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 2 | $282 |
| Aimmune Therapeutics, Inc. | 1 | $125 |
| Abbott Laboratories | 2 | $62 |
Products named: TREMFYA, ZENPEP, SUPERA.
Industry payments across CA — which companies pay providers there.
